Changes in Intracellular Na+ following Enhancement of Late Na+ Current in Virtual Human Ventricular Myocytes.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Action Potentials* ; Models, Cardiovascular*; Heart Failure/*metabolism ; Heart Ventricles/*metabolism ; Myocytes, Cardiac/*metabolism ; Sodium/*metabolism; Animals ; Calcium/metabolism ; Calcium Channels, L-Type/metabolism ; Heart Ventricles/pathology ; Humans ; Rabbits

The slowly inactivating or late Na+ current, INa-L, can contribute to the initiation of both atrial and ventricular rhythm disturbances in the human heart. However, the cellular and molecular mechanisms that underlie these pro-arrhythmic influences are not fully understood. At present, the major working hypothesis is that the Na+ influx corresponding to INa-L significantly increases intracellular Na+, [Na+]i; and the resulting reduction in the electrochemical driving force for Na+ reduces and (may reverse) Na+/Ca2+ exchange. These changes increase intracellular Ca2+, [Ca2+]i; which may further enhance INa-L due to calmodulin-dependent phosphorylation of the Na+ channels. This paper is based on mathematical simulations using the O'Hara et al (2011) model of baseline or healthy human ventricular action potential waveforms(s) and its [Ca2+]i homeostasis mechanisms. Somewhat surprisingly, our results reveal only very small changes (≤ 1.5 mM) in [Na+]i even when INa-L is increased 5-fold and steady-state stimulation rate is approximately 2 times the normal human heart rate (i.e. 2 Hz). Previous work done using well-established models of the rabbit and human ventricular action potential in heart failure settings also reported little or no change in [Na+]i when INa-L was increased. Based on our simulations, the major short-term effect of markedly augmenting INa-L is a significant prolongation of the action potential and an associated increase in the likelihood of reactivation of the L-type Ca2+ current, ICa-L. Furthermore, this action potential prolongation does not contribute to [Na+]i increase.
Competing Interests: The authors have declared that no competing interests exist.

PLoS One. 2012;7(3):e32659. (PMID: 22427860)
Eur Biophys J. 2012 Jun;41(6):491-503. (PMID: 22466899)
Biophys J. 2006 May 1;90(9):3074-90. (PMID: 16473911)
J Physiol. 1981 Aug;317:163-87. (PMID: 7310731)
Circ Res. 2013 Apr 12;112(8):1112-20. (PMID: 23438901)
Heart Rhythm. 2015 Feb;12(2):440-8. (PMID: 25460862)
Cardiovasc Res. 1992 May;26(5):433-42. (PMID: 1332825)
J Mol Cell Cardiol. 2013 Aug;61:2-10. (PMID: 23608603)
Exp Physiol. 2009 May;94(5):520-8. (PMID: 19270038)
J Pharmacol Exp Ther. 2006 Jul;318(1):214-22. (PMID: 16565163)
Circ Res. 2013 Sep 13;113(7):e50-61. (PMID: 23897695)
J Am Coll Cardiol. 1995 Jul;26(1):185-92. (PMID: 7797750)
J Gen Physiol. 2011 Nov;138(5):537-59. (PMID: 22042988)
Circulation. 2013 Feb 5;127(5):575-84. (PMID: 23271797)
J Electrocardiol. 2011 Nov-Dec;44(6):656-61. (PMID: 21908004)
Circ Res. 2015 Jan 2;116(1):127-37. (PMID: 25552692)
J Physiol. 1992;453:219-31. (PMID: 1334512)
J Mol Cell Cardiol. 2005 Mar;38(3):475-83. (PMID: 15733907)
Front Pharmacol. 2014 Mar 10;5:41. (PMID: 24653702)
J Mol Cell Cardiol. 2013 Aug;61:20-7. (PMID: 23727097)
PLoS One. 2014 Sep 05;9(9):e106602. (PMID: 25191998)
Circulation. 2002 Jul 23;106(4):447-53. (PMID: 12135944)
Circulation. 2002 May 28;105(21):2543-8. (PMID: 12034663)
Circulation. 2015 Aug 18;132(7):567-77. (PMID: 26187182)
J Gen Physiol. 2015 May;145(5):395-404. (PMID: 25918358)
J Physiol. 1984 Oct;355:251-66. (PMID: 6092625)
Front Physiol. 2013 Feb 15;4:19. (PMID: 23423152)
Circ Res. 2009 Jul 17;105(2):185-93. (PMID: 19542013)
Biophys J. 2015 Apr 21;108(8):1908-21. (PMID: 25902431)
Am J Physiol Cell Physiol. 2007 Jul;293(1):C321-7. (PMID: 17392375)
J Physiol. 1997 May 1;500 ( Pt 3):631-42. (PMID: 9161981)
J Physiol. 2010 Feb 1;588(Pt 3):465-78. (PMID: 20008467)
J Physiol. 2015 Mar 15;593(6):1429-42. (PMID: 25545172)
Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12):H1680-96. (PMID: 23585132)
Exp Physiol. 1990 Jul;75(4):437-57. (PMID: 2171582)
Diabetes. 2013 Dec;62(12 ):4257-65. (PMID: 23974924)
J Mol Cell Cardiol. 2013 Aug;61:11-9. (PMID: 23774049)
Circ Res. 1989 May;64(5):977-90. (PMID: 2468430)
J Theor Biol. 1988 May 7;132(1):15-27. (PMID: 2461496)
Heart. 2006 Jul;92 Suppl 4:iv1-iv5. (PMID: 16775091)
Circ Res. 2008 Feb 15;102(3):364-71. (PMID: 18048769)
Trends Cardiovasc Med. 2016 Feb;26(2):123-5. (PMID: 26371718)
Biophys J. 2004 Aug;87(2):1360-8. (PMID: 15298938)
Biophys J. 2015 Nov 17;109 (10 ):2037-50. (PMID: 26588563)
J Mol Cell Cardiol. 2008 Jul;45(1):32-43. (PMID: 18439620)
Biophys J. 2015 Nov 3;109 (9):1852-62. (PMID: 26536262)
Biophys J. 2003 Jun;84(6):4157-66. (PMID: 12770918)
J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1:S169-S177. (PMID: 16686675)
Nat Rev Cardiol. 2009 May;6(5):337-48. (PMID: 19377496)
Circ Res. 2006 Jul 21;99(2):172-82. (PMID: 16778127)
Channels (Austin). 2013 Jul-Aug;7(4):249-62. (PMID: 23696033)
Exp Physiol. 2008 Mar;93(3):347-61. (PMID: 17993508)
J Physiol. 1996 Apr 1;492 ( Pt 1):1-19. (PMID: 8730578)
Am J Physiol. 1999 Mar;276(3 Pt 2):H1064-77. (PMID: 10070093)
Heart Rhythm. 2011 Aug;8(8):1281-90. (PMID: 21421082)
Circ Res. 2016 Sep 30;119(8):944-55. (PMID: 27572487)
J Physiol. 2003 Jan 1;546(Pt 1):5-18. (PMID: 12509475)
Circ Res. 1988 Mar;62(3):563-71. (PMID: 2449297)
Cardiovasc Res. 2003 Mar 15;57(4):897-912. (PMID: 12650868)
J Mol Cell Cardiol. 1997 Jan;29(1):85-96. (PMID: 9040024)
J Physiol. 1983 Feb;335:723-43. (PMID: 6875898)
J Mol Cell Cardiol. 2003 Jan;35(1):5-25. (PMID: 12623296)
Circ Res. 2009 Feb 13;104(3):292-303. (PMID: 19213964)
Exp Physiol. 2014 Oct;99(10):1273-82. (PMID: 25128325)
J Mol Cell Cardiol. 2013 Aug;61:44-50. (PMID: 23500390)
PLoS One. 2014 Jul 23;9(7):e103273. (PMID: 25054335)
Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H775-84. (PMID: 19482965)
Pflugers Arch. 1987 Jan;408(1):18-26. (PMID: 2434919)
Circulation. 1994 Jul;90(1):391-9. (PMID: 8026023)
J Physiol. 2001 Oct 15;536(Pt 2):439-43. (PMID: 11600679)
J Mol Cell Cardiol. 2000 Apr;32(4):621-30. (PMID: 10756118)
Heart. 2006 Jul;92 Suppl 4:iv6-iv14. (PMID: 16775092)
Cardiovasc Res. 1997 Aug;35(2):256-72. (PMID: 9349389)
Circ Res. 2011 Mar 4;108(5):555-65. (PMID: 21252154)
Cardiovasc Res. 2015 Feb 1;105(2):171-81. (PMID: 25514933)
Circ Res. 2000 Nov 10;87(10):910-4. (PMID: 11073887)
J Physiol. 2015 Mar 15;593(6):1331-45. (PMID: 25772289)
Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1573-89. (PMID: 14656705)
Acta Physiol Scand. 1996 Mar;156(3):213-25. (PMID: 8729681)
Curr Opin Pharmacol. 2014 Apr;15:53-60. (PMID: 24721654)
J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1:S2-S7. (PMID: 16686677)
J Physiol. 2014 Feb 1;592(3):411-4. (PMID: 24488066)
PLoS Comput Biol. 2011 May;7(5):e1002061. (PMID: 21637795)
Exp Physiol. 2008 Jul;93(7):919-29. (PMID: 18344258)
Trends Cardiovasc Med. 2016 Feb;26(2):115-22. (PMID: 26092781)
Circ Res. 1995 May;76(5):790-801. (PMID: 7728996)
Circ Res. 1999 Jun 25;84(12):1401-6. (PMID: 10381892)
PLoS One. 2014 Jan 08;9(1):e84401. (PMID: 24416228)
J Mol Cell Cardiol. 2015 Dec;89(Pt B):146-59. (PMID: 26476237)
Circ Res. 1989 Feb;64(2):389-97. (PMID: 2536304)
J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1:S47-S56. (PMID: 16686682)
J Physiol. 2014 Feb 1;592(3):415-7. (PMID: 24488067)
Cardiovasc Res. 2003 Mar 15;57(4):1025-34. (PMID: 12650880)
Cell Calcium. 2004 Jun;35(6):603-12. (PMID: 15110150)
Circ Res. 2010 Oct 15;107(8):967-74. (PMID: 20724705)
Basic Res Cardiol. 2011 Nov;106(6):967-77. (PMID: 21779914)
J Physiol. 1981;313:439-61. (PMID: 7277229)
J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1:S15-S20. (PMID: 16686671)

0 (Calcium Channels, L-Type)
9NEZ333N27 (Sodium)
SY7Q814VUP (Calcium)

Date Created: 20161123 Date Completed: 20170622 Latest Revision: 20181113

20221213

PMC5119830

10.1371/journal.pone.0167060

27875582